Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,318 across all filing types
Latest filing 2024-11-27 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about fine notices received by the company's subsidiaries in Germany. It details the nature of the fines, the authority involved, dates, and corrective actions taken. There are no financial statements, earnings data, or detailed management analysis. The document serves as a regulatory announcement about a legal compliance issue rather than a financial report or management discussion. It is a regulatory filing informing the stock exchanges and public about a material event as required by law. Therefore, it fits best under Regulatory Filings (RNS). The document length is about 4600 characters, and it is a direct disclosure, not a report publication announcement or certification.
2024-11-27 English
FORM 6-K
Regulatory Filings
2024-11-26 English
Schedule of Analyst / Institutional Investor Meeting
Capital/Financing Update Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no financial data, no detailed presentation, no report attached or referenced as being published. The document is essentially an announcement of upcoming investor meetings, which fits the category of a Capital/Financing Update as it relates to investor relations activities and company engagement with investors. The document length is short (1229 characters), and it does not contain financial statements or detailed analysis, so it is not an Interim Report or Earnings Release. It is not a Regulatory Filing in the fallback sense because it specifically relates to investor meetings. Therefore, the best classification is Capital/Financing Update (CAP).
2024-11-26 English
Schedule of Analyst / Institutional Investor Meeting
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It is an intimation under SEBI regulations about upcoming investor conferences. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. The document is brief (1233 characters) and serves as an announcement of meetings rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-26 English
6-K Filing
Regulatory Filings
2024-11-26 English
Loss of Share Certificate(s)
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the loss of share certificates by shareholders, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. It lists details of lost share certificates but does not contain financial data, management discussion, or report content. It is an official regulatory announcement related to shareholding records and compliance, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-11-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.